NCT04892173: JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
- State
- Under way
- Phase
- Phase 3
- People
- 500 planned
- Started
- 10 Dec 2021
- Primary completion
- 30 Jun 2028
- Arms
- Arm A: JNJ-90301900 (NBTXR3)
- Results
- None posted
- 19 May 2021: Trial registered
- 10 Dec 2021: Trial started